BeyondSpring Inc. (BYSI)
BYSI Stock Price Chart
Explore BeyondSpring Inc. interactive price chart. Choose custom timeframes to analyze BYSI price movements and trends.
BYSI Company Profile
Discover essential business fundamentals and corporate details for BeyondSpring Inc. (BYSI) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Mar 2017
Employees
40.00
CEO
Lan Huang
Description
BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer. The company is also exploring Plinabulin's efficacy in combination with various immuno-oncology drugs; specifically, alongside nivolumab (a PD-1 antibody) for NSCLC, and with nivolumab and ipilimumab (a CTLA-4 antibody) for small cell lung cancer (SCLC). Furthermore, it is being investigated in conjunction with PD-1 or PD-L1 antibodies and radiation to address a range of cancers. Beyond its lead asset, BeyondSpring's pipeline includes three preclinical-stage small molecule immune agents and a proprietary drug development platform. The company, founded in 2010, maintains its headquarters in New York, New York.
BYSI Financial Timeline
Browse a chronological timeline of BeyondSpring Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 12 Aug 2026
EPS estimate is -$0.54, while revenue estimate is $8.77m.
Earnings released on 13 May 2026
EPS came in at -$0.05 surpassing the estimated -$0.54 by +90.74%.
Earnings released on 25 Mar 2026
EPS came in at -$0.05 surpassing the estimated -$0.54 by +90.26%.
Earnings released on 12 Nov 2025
EPS came in at -$0.05 .
Earnings released on 13 Aug 2025
EPS came in at -$0.04 .
Earnings released on 12 May 2025
EPS came in at -$0.06 .
Earnings released on 27 Mar 2025
EPS came in at $0.08 , while revenue for the quarter reached -$1.44m .
Earnings released on 9 Aug 2024
EPS came in at -$0.09 , while revenue for the quarter reached $500.00k .
Earnings released on 29 Apr 2024
EPS came in at -$0.11 , while revenue for the quarter reached $438.00k , missing expectations by -98.54%.
Earnings released on 11 Apr 2024
EPS came in at -$0.09 , while revenue for the quarter reached $500.00k , missing expectations by -98.33%.
Earnings released on 28 Feb 2024
EPS came in at -$0.16 , while revenue for the quarter reached $437.50k , missing expectations by -98.54%.
Earnings released on 29 Sept 2023
EPS came in at -$0.11 , while revenue for the quarter reached $438.00k .
Earnings released on 18 Apr 2023
EPS came in at -$0.19 surpassing the estimated -$0.58 by +67.41%, while revenue for the quarter reached $337.50k , missing expectations by -98.88%.
Earnings released on 31 Mar 2023
EPS came in at -$0.16 , while revenue for the quarter reached $437.50k .
Earnings released on 28 Feb 2023
EPS came in at -$0.24 , while revenue for the quarter reached $338.00k , missing expectations by -0.59%.
Earnings released on 30 Sept 2022
EPS came in at -$0.19 surpassing the estimated -$0.23 by +17.81%, while revenue for the quarter reached $337.50k , missing expectations by -0.74%.
Earnings released on 14 Apr 2022
EPS came in at -$0.24 surpassing the estimated -$0.26 by +7.69%, while revenue for the quarter reached $338.00k , beating expectations by +25.88%.
Earnings released on 31 Mar 2022
EPS came in at -$0.24 , while revenue for the quarter reached $338.00k .
Earnings released on 30 Dec 2021
EPS came in at -$0.47 surpassing the estimated -$0.58 by +18.97%, while revenue for the quarter reached $337.00k , beating expectations by +98.24%.
Earnings released on 10 Sept 2021
EPS came in at -$0.49 matching the estimated -$0.49, while revenue for the quarter reached $338.00k , missing expectations by -96.14%.
BYSI Stock Performance
Access detailed BYSI performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
